Aquestive Therapeutics
AQST
$4.06
Share price
-5.59%
Change (1 day)
-31.43%
Change (1 year)
Categories
P/S ratio for Aquestive Therapeutics (AQST)
P/S ratio as of April 2025 (TTM): 4.93
According to Aquestive Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -4.72. At the end of 2024 the company had a P/S ratio of 5.58.
P/S ratio history for Aquestive Therapeutics from 2018 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 5.58 | 109.12% |
| 2023 | 2.67 | 160.22% |
| 2022 | 1.02 | -66.66% |
| 2021 | 3.07 | -21.65% |
| 2020 | 3.92 | 41.6% |
| 2019 | 2.77 | 18.88% |
| 2018 | 2.33 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 92.5 | 1,776.34% | 🇺🇸 USA |
 | 1.75 | -64.59% | 🇺🇸 USA |